Skip to main content
Erschienen in: Surgical Endoscopy 6/2011

01.06.2011

Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia

verfasst von: Mitchell Roslin, Tanuja Damani, Jonathan Oren, Robert Andrews, Edward Yatco, Paresh Shah

Erschienen in: Surgical Endoscopy | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Symptoms of reactive hypoglycemia have been reported by patients after Roux-en-Y gastric bypass (RYGB) surgery who experience maladaptive eating behavior and weight regain. A 4-h glucose tolerance test (GTT) was used to assess the incidence and extent of hypoglycemia.

Methods

Thirty-six patients who were at least 6 months postoperative from RYGB were administered a 4-h GTT with measurement of insulin levels. Mean age was 49.4 ± 11.4 years, mean preoperative body mass index (BMI) was 48.8 ± 6.6 kg/m2, percent excess BMI lost (%EBL) was 62.6 ± 21.6%, mean weight change from nadir weight was 8.2 ± 8.6 kg, and mean follow-up time was 40.5 ± 26.7 months. Twelve patients had diabetes preoperatively.

Results

Thirty-two of 36 patients (89%) had abnormal GTT. Six patients (17%) were identified as diabetic based on GTT. All six of these patients were diabetic preoperatively. Twenty-six patients (72%) had evidence of reactive hypoglycemia at 2 h post glucose load. Within this cohort of 26 patients, 14 had maximum to minimum glucose ratio (MMGR) > 3:1, 5 with a ratio > 4:1. Eleven patients had weight regain greater than 10% of initial weight loss (range 4.9–25.6 kg). Ten of these 11 patients (91%) with weight recidivism showed reactive hypoglycemia.

Conclusions

Abnormal GTT is a common finding post RYGB. Persistence of diabetes was noted in 50% of patients with diabetes preoperatively. Amongst the nondiabetic patients, reactive hypoglycemia was found to be more common and pronounced than expected. Absence of abnormally high insulin levels does not support nesidioblastosis as an etiology of this hypoglycemia. More than 50% of patients with reactive hypoglycemia had significantly exaggerated MMGR. We believe this may be due to the nonphysiologic transit of food to the small intestine due to lack of a pyloric valve after RYGB. This reactive hypoglycemia may contribute to maladaptive eating behaviors leading to weight regain long term. Our data suggest that GTT is an important part of post-RYGB follow-up and should be incorporated into the routine postoperative screening protocol. Further studies on the impact of pylorus preservation are necessary.
Literatur
1.
Zurück zum Zitat Manson JE, Skerret PJ, Greenland P, VanItallie TB (2004) The escalating pandemic s of obesity and sedentary lifestyle: a call to action by clinicians. Arch Intern Med 164:249–258PubMedCrossRef Manson JE, Skerret PJ, Greenland P, VanItallie TB (2004) The escalating pandemic s of obesity and sedentary lifestyle: a call to action by clinicians. Arch Intern Med 164:249–258PubMedCrossRef
2.
Zurück zum Zitat Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484PubMed Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484PubMed
3.
Zurück zum Zitat Torquati A, Lutfi R, Abumrad N, Richards WO (2005) Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 9:1112–1116PubMedCrossRef Torquati A, Lutfi R, Abumrad N, Richards WO (2005) Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 9:1112–1116PubMedCrossRef
4.
Zurück zum Zitat Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G, Ren C (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass and biliopancreatic diversion. J Am Coll Surg 205:631–635PubMedCrossRef Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G, Ren C (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass and biliopancreatic diversion. J Am Coll Surg 205:631–635PubMedCrossRef
5.
Zurück zum Zitat Alexandrides TK, Skroubis G, Kalfarentzos F (2007) Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 17:176–184PubMedCrossRef Alexandrides TK, Skroubis G, Kalfarentzos F (2007) Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 17:176–184PubMedCrossRef
6.
Zurück zum Zitat Gumbs AA, Modlin IM, Ballantyne GH (2005) Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 15:462–473PubMedCrossRef Gumbs AA, Modlin IM, Ballantyne GH (2005) Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 15:462–473PubMedCrossRef
7.
Zurück zum Zitat Service FJ, Natt N, Thompson GB, Grant CS, van Heerden JA, Andrews JC, Lorenz E, Terzic A, Lloyd RV (1999) Noninsulinoma pancreatogenous hypoglycemia:a novel syndrome of hyperinsulinemic hypoglycemic in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 84:1582–1589PubMedCrossRef Service FJ, Natt N, Thompson GB, Grant CS, van Heerden JA, Andrews JC, Lorenz E, Terzic A, Lloyd RV (1999) Noninsulinoma pancreatogenous hypoglycemia:a novel syndrome of hyperinsulinemic hypoglycemic in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 84:1582–1589PubMedCrossRef
8.
Zurück zum Zitat Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249–254PubMedCrossRef Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249–254PubMedCrossRef
9.
Zurück zum Zitat Bantle JP, Ikramuddin S, Kellogg TA, Buchwald H (2007) Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg 17:592–594PubMedCrossRef Bantle JP, Ikramuddin S, Kellogg TA, Buchwald H (2007) Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg 17:592–594PubMedCrossRef
10.
Zurück zum Zitat Moreira RO, Moreira RBM, Machado NAM, Goncalves TB, Coutinho WF (2008) Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 18:1618–1621PubMedCrossRef Moreira RO, Moreira RBM, Machado NAM, Goncalves TB, Coutinho WF (2008) Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 18:1618–1621PubMedCrossRef
11.
Zurück zum Zitat Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB (2005) Severe hypoglycemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240PubMedCrossRef Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB (2005) Severe hypoglycemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240PubMedCrossRef
12.
Zurück zum Zitat Clancy TE, Moore FD, Zinner MJ (2006) Post-gastric bypass hyperinsulinism with nesidioblastosis:subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastroint Surg 10:1116–1119CrossRef Clancy TE, Moore FD, Zinner MJ (2006) Post-gastric bypass hyperinsulinism with nesidioblastosis:subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastroint Surg 10:1116–1119CrossRef
13.
Zurück zum Zitat Alvarez GC, Faria EN, Beck M, Girardon DT, Machado AC (2007) Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obes Surg 14:550–552CrossRef Alvarez GC, Faria EN, Beck M, Girardon DT, Machado AC (2007) Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obes Surg 14:550–552CrossRef
14.
Zurück zum Zitat De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA (2003) Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 52:365–371PubMedCrossRef De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA (2003) Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 52:365–371PubMedCrossRef
15.
Zurück zum Zitat List JF, Habener JF (2004) Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta cells. Am J Physiol Endocrinol Metab 286:E875–E881PubMedCrossRef List JF, Habener JF (2004) Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta cells. Am J Physiol Endocrinol Metab 286:E875–E881PubMedCrossRef
16.
Zurück zum Zitat Brubaker PL, Drucker DJ (2004) Minireview: glucagon-like polypeptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology 145:2653–2659PubMedCrossRef Brubaker PL, Drucker DJ (2004) Minireview: glucagon-like polypeptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology 145:2653–2659PubMedCrossRef
17.
Zurück zum Zitat Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and proves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149–5158PubMedCrossRef Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and proves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149–5158PubMedCrossRef
18.
Zurück zum Zitat Meier JJ, Butler AE, Galasso R, Butler PC (2006) Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29:1554–1559PubMedCrossRef Meier JJ, Butler AE, Galasso R, Butler PC (2006) Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29:1554–1559PubMedCrossRef
19.
Zurück zum Zitat Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34:362–366PubMed Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34:362–366PubMed
20.
Zurück zum Zitat Kiens B, Richter EA (1996) Types of carbohydrate in an ordinary diet affect insulin action and muscle substrates in humans. Am J Clin Nutr 63:47–53PubMed Kiens B, Richter EA (1996) Types of carbohydrate in an ordinary diet affect insulin action and muscle substrates in humans. Am J Clin Nutr 63:47–53PubMed
22.
Zurück zum Zitat Linner JH (1982) Comparative effectiveness of gastric bypass and gastroplasty. Arch Surg 117:695–700PubMed Linner JH (1982) Comparative effectiveness of gastric bypass and gastroplasty. Arch Surg 117:695–700PubMed
23.
Zurück zum Zitat Laws HL, Piantadosi S (1980) Superior gastric reduction procedure for morbid obesity. A prospective randomized trial. Ann Surg 193:334–336CrossRef Laws HL, Piantadosi S (1980) Superior gastric reduction procedure for morbid obesity. A prospective randomized trial. Ann Surg 193:334–336CrossRef
24.
Zurück zum Zitat Pories WJ, Flickinger EG, Meelheim D, Van Rij AM, Thomas FT (1982) The effectiveness of gastric bypass over gastric partition in morbid obesity: consequences of distal gastric and duodenal exclusion. Ann Surg 196:389–399PubMedCrossRef Pories WJ, Flickinger EG, Meelheim D, Van Rij AM, Thomas FT (1982) The effectiveness of gastric bypass over gastric partition in morbid obesity: consequences of distal gastric and duodenal exclusion. Ann Surg 196:389–399PubMedCrossRef
25.
Zurück zum Zitat Sugerman HJ, Starkey JV, Birkenhauer R (1987) A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 205:613–622PubMedCrossRef Sugerman HJ, Starkey JV, Birkenhauer R (1987) A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 205:613–622PubMedCrossRef
26.
Zurück zum Zitat Sugerman HJ, Wolper HL (1984) Failed gastroplasty for morbid obesity: revised gastroplasty vs. Roux-en-Y gastric bypass. Am J Surg 148:331–336PubMedCrossRef Sugerman HJ, Wolper HL (1984) Failed gastroplasty for morbid obesity: revised gastroplasty vs. Roux-en-Y gastric bypass. Am J Surg 148:331–336PubMedCrossRef
27.
Zurück zum Zitat Eckhauser FE, Knoll JA, Strodel WE (1983) Remedial surgery following failed gastroplasty for morbid obesity. Ann Surg 198:585–591PubMedCrossRef Eckhauser FE, Knoll JA, Strodel WE (1983) Remedial surgery following failed gastroplasty for morbid obesity. Ann Surg 198:585–591PubMedCrossRef
28.
Zurück zum Zitat Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC (2008) Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg 18:648–651PubMedCrossRef Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC (2008) Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg 18:648–651PubMedCrossRef
29.
Zurück zum Zitat Christou NV, Look D, Maclean LD (2006) Weight gain after short-and long-limb gastric bypass in patients followed longer than 10 years. Ann Surg 244:734–740PubMedCrossRef Christou NV, Look D, Maclean LD (2006) Weight gain after short-and long-limb gastric bypass in patients followed longer than 10 years. Ann Surg 244:734–740PubMedCrossRef
30.
Zurück zum Zitat Loewen M, Barba C (2008) Endoscopic sclerotherpy for dilated gastrojejunostomy of failed gastric bypass. Surg Obes Relat Dis 4:539–542PubMedCrossRef Loewen M, Barba C (2008) Endoscopic sclerotherpy for dilated gastrojejunostomy of failed gastric bypass. Surg Obes Relat Dis 4:539–542PubMedCrossRef
31.
Zurück zum Zitat Thompson CC, Slattery J, Bundga ME, Lautz DB (2006) Preoral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc 20:1744–1748PubMedCrossRef Thompson CC, Slattery J, Bundga ME, Lautz DB (2006) Preoral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc 20:1744–1748PubMedCrossRef
32.
Zurück zum Zitat Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630PubMedCrossRef Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630PubMedCrossRef
33.
Zurück zum Zitat Kalarchian MA, Marcus MD, Wilson GT, Labouvie EW, Brolin RE, LaMarca LB (2002) Binge eating among gastric bypass patients and long-term follow-up. Obes Surg 12:270–275PubMedCrossRef Kalarchian MA, Marcus MD, Wilson GT, Labouvie EW, Brolin RE, LaMarca LB (2002) Binge eating among gastric bypass patients and long-term follow-up. Obes Surg 12:270–275PubMedCrossRef
Metadaten
Titel
Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia
verfasst von
Mitchell Roslin
Tanuja Damani
Jonathan Oren
Robert Andrews
Edward Yatco
Paresh Shah
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 6/2011
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-010-1489-9

Weitere Artikel der Ausgabe 6/2011

Surgical Endoscopy 6/2011 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.